Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 27% ± 8% | |
oligodendrocyte | 4 studies | 16% ± 1% | |
hematopoietic precursor cell | 3 studies | 17% ± 1% | |
ciliated cell | 3 studies | 19% ± 1% | |
erythroblast | 3 studies | 30% ± 12% | |
GABAergic neuron | 3 studies | 26% ± 4% | |
glutamatergic neuron | 3 studies | 38% ± 8% | |
dendritic cell | 3 studies | 24% ± 3% | |
natural killer cell | 3 studies | 20% ± 5% | |
CD4-positive, alpha-beta T cell | 3 studies | 18% ± 2% | |
CD8-positive, alpha-beta T cell | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 26% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 863.16 | 245 / 245 | 100% | 11.95 | 502 / 502 |
brain | 100% | 884.84 | 2638 / 2642 | 100% | 11.41 | 705 / 705 |
uterus | 100% | 718.86 | 170 / 170 | 100% | 12.59 | 458 / 459 |
bladder | 100% | 678.81 | 21 / 21 | 99% | 9.08 | 501 / 504 |
thymus | 100% | 490.10 | 652 / 653 | 99% | 6.95 | 601 / 605 |
breast | 100% | 689.42 | 459 / 459 | 99% | 12.63 | 1104 / 1118 |
esophagus | 100% | 632.19 | 1442 / 1445 | 99% | 6.48 | 181 / 183 |
lung | 99% | 506.83 | 571 / 578 | 100% | 8.46 | 1151 / 1155 |
skin | 100% | 575.77 | 1802 / 1809 | 99% | 11.59 | 466 / 472 |
stomach | 100% | 555.24 | 359 / 359 | 98% | 6.07 | 281 / 286 |
ovary | 100% | 689.74 | 180 / 180 | 98% | 6.68 | 420 / 430 |
pancreas | 98% | 280.19 | 323 / 328 | 98% | 5.70 | 175 / 178 |
intestine | 100% | 652.44 | 962 / 966 | 97% | 6.15 | 511 / 527 |
adrenal gland | 100% | 833.98 | 258 / 258 | 96% | 7.42 | 221 / 230 |
kidney | 100% | 533.04 | 89 / 89 | 95% | 5.89 | 853 / 901 |
liver | 96% | 263.04 | 217 / 226 | 96% | 5.35 | 390 / 406 |
blood vessel | 100% | 830.75 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 14.84 | 29 / 29 |
spleen | 100% | 735.54 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.07 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.81 | 1 / 1 |
adipose | 100% | 644.17 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 463.36 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 770.80 | 843 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 6.76 | 76 / 80 |
peripheral blood | 55% | 478.34 | 507 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007062 | Biological process | sister chromatid cohesion |
GO_0006281 | Biological process | DNA repair |
GO_0007283 | Biological process | spermatogenesis |
GO_0010971 | Biological process | positive regulation of G2/M transition of mitotic cell cycle |
GO_0007066 | Biological process | female meiosis sister chromatid cohesion |
GO_0007131 | Biological process | reciprocal meiotic recombination |
GO_0000722 | Biological process | telomere maintenance via recombination |
GO_0007141 | Biological process | male meiosis I |
GO_0000724 | Biological process | double-strand break repair via homologous recombination |
GO_0000707 | Biological process | meiotic DNA recombinase assembly |
GO_0006310 | Biological process | DNA recombination |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0005657 | Cellular component | replication fork |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0033063 | Cellular component | Rad51B-Rad51C-Rad51D-XRCC2 complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0030054 | Cellular component | cell junction |
GO_0033065 | Cellular component | Rad51C-XRCC3 complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0008821 | Molecular function | crossover junction DNA endonuclease activity |
GO_0140664 | Molecular function | ATP-dependent DNA damage sensor activity |
GO_0000400 | Molecular function | four-way junction DNA binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RAD51C |
Protein name | DNA repair protein RAD51 homolog 3 DNA repair protein RAD51 homolog 3 (R51H3) (RAD51 homolog C) (RAD51-like protein 2) RAD51 paralog C RAD51 homolog C (S. cerevisiae) (RAD51 paralog C) (RAD51C protein) (cDNA FLJ76539, highly similar to Homo sapiens RAD51 homolog C (S. cerevisiae) (RAD51C), transcript variant 3, mRNA) |
Synonyms | RAD51L2 hCG_2000975 |
Description | FUNCTION: Essential for the homologous recombination (HR) pathway of DNA repair. Involved in the homologous recombination repair (HRR) pathway of double-stranded DNA breaks arising during DNA replication or induced by DNA-damaging agents. Part of the RAD51 paralog protein complexes BCDX2 and CX3 which act at different stages of the BRCA1-BRCA2-dependent HR pathway. Upon DNA damage, BCDX2 seems to act downstream of BRCA2 recruitment and upstream of RAD51 recruitment; CX3 seems to act downstream of RAD51 recruitment; both complexes bind predominantly to the intersection of the four duplex arms of the Holliday junction (HJ) and to junction of replication forks. The BCDX2 complex was originally reported to bind single-stranded DNA, single-stranded gaps in duplex DNA and specifically to nicks in duplex DNA. The BCDX2 subcomplex RAD51B:RAD51C exhibits single-stranded DNA-dependent ATPase activity suggesting an involvement in early stages of the HR pathway. Involved in RAD51 foci formation in response to DNA damage suggesting an involvement in early stages of HR probably in the invasion step. Has an early function in DNA repair in facilitating phosphorylation of the checkpoint kinase CHEK2 and thereby transduction of the damage signal, leading to cell cycle arrest and HR activation. Participates in branch migration and HJ resolution and thus is important for processing HR intermediates late in the DNA repair process; the function may be linked to the CX3 complex. Part of a PALB2-scaffolded HR complex containing BRCA2 and which is thought to play a role in DNA repair by HR. Protects RAD51 from ubiquitin-mediated degradation that is enhanced following DNA damage. Plays a role in regulating mitochondrial DNA copy number under conditions of oxidative stress in the presence of RAD51 and XRCC3. Contributes to DNA cross-link resistance, sister chromatid cohesion and genomic stability. Involved in maintaining centrosome number in mitosis. . |
Accessions | ENST00000461271.6 J3QKK3 ENST00000697686.1 ENST00000697681.1 ENST00000486827.1 A0A8V8TML8 ENST00000413590.5 ENST00000584617.5 ENST00000583539.5 A0A087WZ35 O43502 ENST00000697685.1 J3QLQ2 ENST00000697680.1 ENST00000697694.1 A0A8V8TMU8 J3QLB5 ENST00000475762.5 ENST00000697689.1 ENST00000584804.1 ENST00000697690.1 ENST00000487525.5 ENST00000697692.1 E9PI66 A0A8V8TML3 ENST00000697683.1 ENST00000421782.3 [O43502-2] H7C1R0 ENST00000482007.5 A0A8V8TL64 Q7KZJ0 J3QR58 ENST00000337432.9 [O43502-1] ENST00000622327.4 ENST00000697691.1 H7C2Q5 ENST00000425173.5 |